These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 10806599)

  • 1. Rank power of metrics used to assess QTc interval prolongation by clinical trial simulation.
    Bonate PL
    J Clin Pharmacol; 2000 May; 40(5):468-74. PubMed ID: 10806599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring the effects of supratherapeutic doses of levofloxacin on healthy volunteers using four methods of QT correction and periodic and continuous ECG recordings.
    Noel GJ; Goodman DB; Chien S; Solanki B; Padmanabhan M; Natarajan J
    J Clin Pharmacol; 2004 May; 44(5):464-73. PubMed ID: 15102866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Randomized Trial to Assess the Effect of Doravirine on the QTc Interval Using a Single Supratherapeutic Dose in Healthy Adult Volunteers.
    Khalilieh SG; Yee KL; Fan L; Liu R; Heber W; Dunzo E; Triantafyllou I; Hussaini A; Iwamoto M
    Clin Drug Investig; 2017 Oct; 37(10):975-984. PubMed ID: 28785879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling the effect of sevoflurane on corrected QT prolongation: a pharmacodynamic analysis.
    Han DW; Park K; Jang SB; Kern SE
    Anesthesiology; 2010 Oct; 113(4):806-11. PubMed ID: 20808206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic-pharmacodynamic modeling in the data analysis and interpretation of drug-induced QT/QTc prolongation.
    Piotrovsky V
    AAPS J; 2005 Oct; 7(3):E609-24. PubMed ID: 16353940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Not-in-trial simulation I: Bridging cardiovascular risk from clinical trials to real-life conditions.
    Chain AS; Dieleman JP; van Noord C; Hofman A; Stricker BH; Danhof M; Sturkenboom MC; Della Pasqua O
    Br J Clin Pharmacol; 2013 Dec; 76(6):964-72. PubMed ID: 23617533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sample size, power calculations, and their implications for the cost of thorough studies of drug induced QT interval prolongation.
    Malik M; Hnatkova K; Batchvarov V; Gang Y; Smetana P; Camm AJ
    Pacing Clin Electrophysiol; 2004 Dec; 27(12):1659-69. PubMed ID: 15613131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deferasirox does not induce QT/QTc-prolongation in healthy subjects.
    Sechaud R; Dumortier T; Balez S
    Int J Clin Pharmacol Ther; 2009 May; 47(5):321-7. PubMed ID: 19473594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is a thorough QTc study necessary? The role of modeling and simulation in evaluating the QTc prolongation potential of drugs.
    Rohatagi S; Carrothers TJ; Kuwabara-Wagg J; Khariton T
    J Clin Pharmacol; 2009 Nov; 49(11):1284-96. PubMed ID: 19734373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic and pharmacodynamic modeling of the effects of oral and intravenous administrations of dofetilide on ventricular repolarization.
    Le Coz F; Funck-Brentano C; Morell T; Ghadanfar MM; Jaillon P
    Clin Pharmacol Ther; 1995 May; 57(5):533-42. PubMed ID: 7768076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Literature review and pilot studies of the effect of QT correction formulas on reported beta2-agonist-induced QTc prolongation.
    Milic M; Bao X; Rizos D; Liu F; Ziegler MG
    Clin Ther; 2006 Apr; 28(4):582-90. PubMed ID: 16750469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statistical issues of QT prolongation assessment based on linear concentration modeling.
    Tsong Y; Shen M; Zhong J; Zhang J
    J Biopharm Stat; 2008; 18(3):564-84. PubMed ID: 18470764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levofloxacin-Induced QTc Prolongation Depends on the Time of Drug Administration.
    Kervezee L; Gotta V; Stevens J; Birkhoff W; Kamerling I; Danhof M; Meijer JH; Burggraaf J
    CPT Pharmacometrics Syst Pharmacol; 2016 Sep; 5(9):466-74. PubMed ID: 27479699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of a probabilistic method for the determination of drug-induced QT prolongation in telemetered cynomolgus monkeys: effects of moxifloxacin.
    Holzgrefe HH; Cavero I; Buchanan LV; Gill MW; Durham SK
    J Pharmacol Toxicol Methods; 2007; 55(3):227-37. PubMed ID: 17097307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loratadine and terfenadine interaction with nefazodone: Both antihistamines are associated with QTc prolongation.
    Abernethy DR; Barbey JT; Franc J; Brown KS; Feirrera I; Ford N; Salazar DE
    Clin Pharmacol Ther; 2001 Mar; 69(3):96-103. PubMed ID: 11240972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epinephrine-induced QT interval prolongation: a gene-specific paradoxical response in congenital long QT syndrome.
    Ackerman MJ; Khositseth A; Tester DJ; Hejlik JB; Shen WK; Porter CB
    Mayo Clin Proc; 2002 May; 77(5):413-21. PubMed ID: 12004990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Droperidol and ondansetron-induced QT interval prolongation: a clinical drug interaction study.
    Charbit B; Alvarez JC; Dasque E; Abe E; Démolis JL; Funck-Brentano C
    Anesthesiology; 2008 Aug; 109(2):206-12. PubMed ID: 18648229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity of common marmosets to detect drug-induced QT interval prolongation: moxifloxacin case study.
    Komatsu R; Honda M; Holzgrefe HH; Kubo J; Yamada Y; Isobe T; Kimura K; Itoh T; Tamaoki N; Tabo M
    J Pharmacol Toxicol Methods; 2010; 61(3):271-6. PubMed ID: 20097298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of tafamidis on the QTc interval in healthy subjects.
    Klamerus KJ; Watsky E; Moller R; Wang R; Riley S
    Br J Clin Pharmacol; 2015 Jun; 79(6):918-25. PubMed ID: 25546001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Pradigastat, a Diacylglycerol Acyltransferase 1 Inhibitor, on the QTcF Interval in Humans.
    Meyers CD; Noe A; Salunke A; Movva A; Kulmatycki K; Neelakantham S; Crissey A; Majumdar T; Chen J
    Clin Pharmacol Drug Dev; 2016 Nov; 5(6):450-459. PubMed ID: 27274009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.